NYGC In the News: An Introduction to the New York Genome Center and a Look at Its Pioneering Work in ALS

Rare neurological disease article graphic

The pioneering work of the Center for Genomics of Neurodegenerative Disease (CGND) at the New York Genome Center (NYGC) is profiled in a four-page article in the “Rare Neurological Disease Special Report” published by Neurology Reviews in March 2019.

In the profile, Hemali Phatnani, PhD, Director, CGND, discusses the CGND’s key goals: serving as a hub for collaboration, building tools and resources for the research community, and conducting key research initiatives, including current studies in cell-cell interactions using spatial transcriptomics.

  • Read the CGND profile here.
  • Read the complete special report here.